Related references
Note: Only part of the references are listed.Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review
Nishant Munugala et al.
HEPATOBILIARY SURGERY AND NUTRITION (2022)
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
Manoj Garg et al.
MEDICINAL RESEARCH REVIEWS (2021)
Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review
Anthony Vignone et al.
JOURNAL OF CLINICAL MEDICINE (2021)
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Junnv Xu et al.
FRONTIERS IN ONCOLOGY (2021)
Patterns of Whole Exome Sequencing in Resected Cholangiocarcinoma
Lucas W. Thornblade et al.
CANCERS (2021)
L-fucose ameliorates the carcinogenic properties of Fusobacterium nucleatum in colorectal cancer
Caihan Duan et al.
ONCOLOGY LETTERS (2021)
Micro RNA Expression after Ingestion of Fucoidan; A Clinical Study
Nuri Gueven et al.
MARINE DRUGS (2020)
Fucoidan from Laminaria japonica exerts antitumor effects on angiogenesis and micrometastasis in triple-negative breast cancer cells
Wen-Jing Hsu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Anatomical, histomorphological and molecular classification of cholangiocarcinoma
Timothy Kendall et al.
LIVER INTERNATIONAL (2019)
miRNAs in drug response variability: potential utility as biomarkers for personalized medicine
Andrea Latini et al.
PHARMACOGENOMICS (2019)
Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma
Sarah Ursu et al.
ONCOGENESIS (2019)
Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer
Jian-Feng Liu et al.
MOLECULAR CARCINOGENESIS (2018)
Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma
Xiang Wang et al.
CANCER BIOMARKERS (2018)
The role of miR-92b in cholangiocarcinoma patients
Min-hang Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management
Irai S. Oliveira et al.
ABDOMINAL RADIOLOGY (2017)
Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells
Christian Lis et al.
SCIENTIFIC REPORTS (2017)
miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth
Yuyan Han et al.
JOURNAL OF HEPATOLOGY (2016)
Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer
Jia Sun et al.
SCIENTIFIC REPORTS (2016)
The role of miRNAs in cholangiocarcinoma
Jessica A. Howell et al.
HEPATIC ONCOLOGY (2016)
MicroRNAs in the Biology and Diagnosis of Cholangiocarcinoma
Klaus Piontek et al.
SEMINARS IN LIVER DISEASE (2015)
Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells
K. S. Siveen et al.
BRITISH JOURNAL OF CANCER (2014)
Oncogenic roles of EMT-inducing transcription factors
Alain Puisieux et al.
NATURE CELL BIOLOGY (2014)
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
Pasquale Sansone et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
Introducing α(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth
Sylvie Mathieu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Signal transducer and activator of transcription proteins in leukemias
M Benekli et al.
BLOOD (2003)
Share Paper
